62.84% | % of shares held by all insiders |
18.27% | % of shares held by institutions |
49.15% | % of float held by institutions |
472 | Number of institutions holding shares |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
Baillie Gifford and Company | 8,358,939 | 30 Mar 2024 | 3.52% | 769,523,903 |
Primecap Management Company | 4,763,453 | 30 Dec 2023 | 2.00% | 438,523,471 |
Temasek Holdings (Private) Limited | 4,518,080 | 30 Dec 2023 | 1.90% | 415,934,433 |
Harding Loevner LLC | 3,944,474 | 30 Dec 2023 | 1.66% | 363,128,266 |
Flossbach von Storch AG | 3,468,986 | 30 Mar 2024 | 1.46% | 319,354,842 |
Blackrock Inc. | 1,640,016 | 30 Dec 2023 | 0.69% | 150,979,868 |
Ubs Asset Management Americas Inc | 995,253 | 30 Dec 2023 | 0.42% | 91,622,988 |
Capital World Investors | 938,747 | 30 Dec 2023 | 0.39% | 86,421,046 |
Altrinsic Global Advisors, LLC | 754,388 | 30 Dec 2023 | 0.32% | 69,448,957 |
Quinn Opportunity Partners, LLC | 674,583 | 30 Dec 2023 | 0.28% | 62,102,109 |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
Vanguard Horizon Fund-Capital Opportunity Fund | 2,357,736 | 30 Dec 2023 | 0.99% | 217,053,170 |
Harding, Loevner Funds, Inc-International Equity Portfolio | 1,890,737 | 30 Jan 2024 | 0.80% | 174,061,243 |
iShares Biotechnology ETF | 1,552,394 | 30 Mar 2024 | 0.65% | 142,913,387 |
Primecap Odyssey Aggressive Growth Fund | 1,362,792 | 30 Mar 2024 | 0.57% | 125,458,628 |
New Perspective Fund Inc | 799,519 | 30 Mar 2024 | 0.34% | 73,603,717 |
Primecap Odyssey Growth Fund | 437,900 | 30 Mar 2024 | 0.18% | 40,313,072 |
Baron Focused Growth Fund | 200,000 | 30 Dec 2023 | 0.08% | 18,411,999 |
Legg Mason Glb Asset Mgt Tr-Clearbridge Value Trust | 200,000 | 30 Jan 2024 | 0.08% | 18,411,999 |
Baillie Gifford Long Term Global Growth Fund | 119,361 | 30 Dec 2023 | 0.05% | 10,988,373 |
Baillie Gifford International Alpha Fund | 124,789 | 30 Dec 2023 | 0.05% | 11,488,075 |